Kazunori Tomono

Author PubWeight™ 45.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical and bacteriological characteristics of IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa. Clin Infect Dis 2003 1.70
2 Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli. Int J Antimicrob Agents 2010 1.67
3 Long-term macrolide antibiotic therapy in the treatment of chronic small airway disease clinically mimicking diffuse panbronchiolitis. Intern Med 2005 1.41
4 Fatal sepsis caused by an unusual Klebsiella species that was misidentified by an automated identification system. J Med Microbiol 2013 1.22
5 Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection. Antimicrob Agents Chemother 2002 1.17
6 Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane. Antimicrob Agents Chemother 2005 1.12
7 Repression of bleomycin-induced pneumopathy by TNF. J Immunol 2003 1.07
8 Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 Cells. Antimicrob Agents Chemother 2004 1.05
9 Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model. J Antimicrob Chemother 2002 1.03
10 Clinical practice guidelines for nursing- and healthcare-associated pneumonia (NHCAP) [complete translation]. Respir Investig 2013 1.02
11 Mycobacterium avium complex pleuritis. Respiration 2002 0.99
12 Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis. Am J Physiol Lung Cell Mol Physiol 2003 0.98
13 Methicillin-resistant Staphylococcus aureus bacteremia at a university hospital in Japan. J Infect Chemother 2012 0.95
14 Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan. J Infect Chemother 2010 0.92
15 Nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa caused by damaged transesophageal echocardiogram probe used in cardiovascular surgical operations. J Infect Chemother 2013 0.91
16 Impact of antimicrobial stewardship by infection control team in a Japanese teaching hospital. Yakugaku Zasshi 2010 0.91
17 Effects of DQ-113, a new quinolone, against methicillin- and vancomycin-resistant Staphylococcus aureus-caused hematogenous pulmonary infections in mice. Antimicrob Agents Chemother 2003 0.90
18 In vivo efficacy of a new quinolone, DQ-113, against Streptococcus pneumoniae in a mouse model. Antimicrob Agents Chemother 2003 0.87
19 Effect of erythromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model. Antimicrob Agents Chemother 2004 0.87
20 Role of Pseudomonas aeruginosa quorum-sensing systems in a mouse model of chronic respiratory infection. J Med Microbiol 2005 0.86
21 Dynamic changes in the expression of neutrophil extracellular traps in acute respiratory infections. Am J Respir Crit Care Med 2012 0.85
22 Emergence of linezolid-resistant mutants in a susceptible-cell population of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2011 0.85
23 Effects of short interfering RNA against methicillin-resistant Staphylococcus aureus coagulase in vitro and in vivo. J Antimicrob Chemother 2005 0.85
24 [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2001)]. Jpn J Antibiot 2003 0.85
25 [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2000)]. Jpn J Antibiot 2002 0.84
26 Development of a novel antimicrobial peptide, AG-30, with angiogenic properties. J Cell Mol Med 2008 0.84
27 Intrapulmonary pharmacokinetics of telithromycin, a new ketolide, in healthy Japanese volunteers. Antimicrob Agents Chemother 2002 0.84
28 Potency of DX-619, a novel des-F(6)-quinolone, in haematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus. Int J Antimicrob Agents 2006 0.83
29 Clinical similarities and differences between human T-cell lymphotropic virus type 1-associated bronchiolitis and diffuse panbronchiolitis. Chest 2004 0.82
30 Role of elastase in a mouse model of chronic respiratory Pseudomonas aeruginosa infection that mimics diffuse panbronchiolitis. J Med Microbiol 2003 0.82
31 Efficacy of quinupristin-dalfopristin against methicillin-resistant Staphylococcus aureus and vancomycin-insensitive S. aureus in a model of hematogenous pulmonary infection. Chemotherapy 2004 0.82
32 In vivo efficacies and pharmacokinetics of DX-619, a novel des-fluoro(6) quinolone, against Streptococcus pneumoniae in a mouse lung infection model. Antimicrob Agents Chemother 2006 0.82
33 Increase of apoptosis in a murine model for severe pneumococcal pneumonia during influenza A virus infection. Jpn J Infect Dis 2011 0.80
34 Patterns of Gram-stained fecal flora as a quick diagnostic marker in patients with severe SIRS. Dig Dis Sci 2010 0.80
35 A probable case of aspiration pneumonia caused by Candida glabrata in a non-neutropenic patient with candidemia. Intern Med 2005 0.80
36 Correlation between outbreaks of multidrug-resistant Pseudomonas aeruginosa infection and use of bronchoscopes suggested by epidemiological analysis. Biol Pharm Bull 2014 0.80
37 Effect of gatifloxacin against Mycoplasma genitalium-related urethritis: an open clinical trial. Sex Transm Infect 2011 0.80
38 Antimicrobial susceptibilities of potential bacterial pathogens in adults with acute respiratory tract infections Prospective Epidemiological Network Investigating Community-acquired Infection SurveiLLance In Nagasaki (PENICILLIN) Study. Diagn Microbiol Infect Dis 2005 0.80
39 Pneumorachis associated with multiorgan infection due to Citrobacter koseri. Diagn Microbiol Infect Dis 2013 0.79
40 Case of invasive nontypable Haemophilus influenzae respiratory tract infection with a large quantity of neutrophil extracellular traps in sputum. J Inflamm Res 2012 0.79
41 Overproduction of MUC5AC core protein in patients with diffuse panbronchiolitis. Respiration 2003 0.79
42 Identification of neutrophil extracellular traps in the blood of patients with systemic inflammatory response syndrome. J Int Med Res 2013 0.79
43 Modification of a novel angiogenic peptide, AG30, for the development of novel therapeutic agents. J Cell Mol Med 2012 0.78
44 The expression of pro- and anti-apoptotic Bcl-2 family proteins in peribronchiolar lymphocytes from patients with diffuse panbronchiolitis. Respir Med 2006 0.78
45 Loading regimen required to rapidly achieve therapeutic trough plasma concentration of teicoplanin and evaluation of clinical features. Clin Pharmacol 2012 0.78
46 Preemptive antibiotic treatment based on gram staining reduced the incidence of ARDS in mechanically ventilated patients. J Trauma 2008 0.77
47 The first telithromycin-resistant Streptococcus pneumoniae isolate in Japan associated with erm(B) and mutations in 23S rRNA and riboprotein L4. Jpn J Infect Dis 2007 0.77
48 Clinical comparative study of sulbactam/ampicillin and imipenem/cilastatin in elderly patients with community-acquired pneumonia. Intern Med 2006 0.76
49 Correlation between the consumption of meropenem or doripenem and meropenem susceptibility of Pseudomonas aeruginosa in a university hospital in Japan. Biol Pharm Bull 2012 0.76
50 Effect of sequential combination of amphotericin B and azole antifungal agents against Aspergillus fumigatus. J Infect Chemother 1999 0.76
51 High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure. Clin Pharmacol 2013 0.76
52 Two sporadic cases of infections due to Klebsiella pneumoniae resistant to expanded-spectrum cephalosporins in Japan. J Infect Chemother 1999 0.75
53 Clinical effects of 2 days of treatment by fosfomycin calcium for acute uncomplicated cystitis in women. J Infect Chemother 2010 0.75
54 Fulminant pneumonia caused by nontypable haemophilus influenzae. Intern Med 2012 0.75
55 Pancreatic Neuroendocrine Tumor Abnormally Secreting Procalcitonin. Pancreas 2017 0.75
56 A Chronic Respiratory Pasteurella multocida Infection Is Well-Controlled by Long-Term Macrolide Therapy. Intern Med 2016 0.75
57 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2000). II. Background of patients]. Jpn J Antibiot 2002 0.75
58 [Blood test-importance of C-reactive protein]. Nihon Naika Gakkai Zasshi 2011 0.75
59 [Hospital infections: progress in their diagnosis, treatment and prevention. Discussion]. Nihon Naika Gakkai Zasshi 2008 0.75
60 Clinical characteristics of pneumonia caused by penicillin resistant and sensitive Streptococcus pneumoniae in Japan. Intern Med 2004 0.75
61 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2001). I. Susceptibility distribution]. Jpn J Antibiot 2003 0.75
62 Mycobacterium avium complex-associated peritonitis with CAPD after unrelated bone marrow transplantation. Pediatr Int 2014 0.75
63 Olecranon Osteomyelitis Caused by Mycobacterium chelonae. Intern Med 2016 0.75
64 Compliance with oral antibiotic regimens and associated factors in Japan: compliance survey of multiple oral antibiotics (COSMOS). Scand J Infect Dis 2011 0.75
65 [Hantavirus pulmonary syndrome]. Nihon Naika Gakkai Zasshi 2004 0.75
66 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2000). I. Susceptibility distribution]. Jpn J Antibiot 2002 0.75
67 Pharmacodynamics and bactericidal activity of gatifloxacin in experimental pneumonia caused by penicillin-resistant Streptococcus pneumoniae. Chemotherapy 2004 0.75
68 A Necrotized Eyelid. Intern Med 2016 0.75
69 Telithromycin inhibits the number of viable bacteria but not lymphocyte accumulation in a murine model of chronic respiratory infection. Chemotherapy 2006 0.75
70 [Comparative studies on activities on antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2000). III. Secular changes in susceptibility]. Jpn J Antibiot 2002 0.75
71 Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan. Kansenshogaku Zasshi 2015 0.75
72 [Analysis of tuberculin skin test in employees of Nagasaki University Hospital]. Kansenshogaku Zasshi 2003 0.75
73 [Our experience using "Huber Plus" needles in our infusion center]. Gan To Kagaku Ryoho 2008 0.75
74 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2001). III. Secular changes in susceptibility]. Jpn J Antibiot 2003 0.75
75 Hospital-acquired pneumonia in general wards of a Japanese tertiary hospital. Respirology 2004 0.75
76 [The role of neutrophil extracellular traps -a translational research between infection and allergy]. Arerugi 2012 0.75
77 [Successful treatment with linezolid in two cases of methicillin-resistant Staphylococcus aureus infections in the orthopedic field]. Kansenshogaku Zasshi 2003 0.75
78 Capnocytophaga ochracea-related Bacterium Bacteremia in a Hypertrophic Cardiomyopathy Patient without Neutropenia. Intern Med 2016 0.75
79 Limited detectability of linezolid-resistant Staphylococcus aureus by the Etest method and its improvement using enriched media. J Med Microbiol 2012 0.75
80 [Infectious diseases: progress in diagnosis and treatment topics: I. Infectious diseases in unusual circumstances. 2. The issue raised by 2011 NHCAP guideline in Japan]. Nihon Naika Gakkai Zasshi 2012 0.75
81 [Two cases of Legionella pneumophila pneumonia improved by parenteral ciprofloxacin administration]. Nihon Kokyuki Gakkai Zasshi 2003 0.75
82 [The new method for detecting the outbreak sign of MRSA]. Kansenshogaku Zasshi 2010 0.75
83 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2001). II. Background of patients]. Jpn J Antibiot 2003 0.75
84 Novel and Simple Approach to Estimating the Actual Incidence of Blood and Body Fluid Exposure. Clin Lab 2017 0.75
85 Efficacy of long-term macrolide antibiotic therapy in patients with diffuse panbronchiolitis: comparison between HLA-B54-positive and -negative cases. Int J Antimicrob Agents 2004 0.75